Brief: ORIC Pharmaceuticals Q3 Net Income USD -32.587 Million
13/11/2025 21:10
Nov 13 (Reuters) - ORIC Pharmaceuticals Q3 operating expenses USD 36.671 million. Q3 income from operations USD -36.671 million
Recent news on ORIC Pharmaceuticals
See all newsBrief: Oric® Pharmaceuticals Announces Agreement With Cancer Research UK
ORIC Pharmaceuticals Q1 net loss widens on higher R&D costs
Brief: ORIC Pharmaceuticals Q1 Operating Expenses USD 39.619 Million
Brief: Oric Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
ORIC Pharmaceuticals Q4 loss narrows